Final answer:
Cholinesterase inhibitors like rivastigmine improve cognitive function in Alzheimer's disease by preventing the breakdown of acetylcholine, thus enhancing communication between neurons.
Step-by-step explanation:
Cholinesterase inhibitors, such as rivastigmine (Exelon), are medications used to treat Alzheimer's disease by enhancing cognitive function. They do so by preventing the breakdown of the neurotransmitter acetylcholine (ACh), which is critical for memory, thought, and judgment. Normally, ACh is hydrolyzed by the enzyme acetylcholinesterase (AChE) into choline and acetic acid, which allows a cholinergic neuron to return to its resting state after activation. Cholinesterase inhibitors block this enzyme, resulting in increased levels of ACh in the synaptic cleft, and thereby improving communication between neurons. This increased communication is believed to help ameliorate symptoms and slow the progression of Alzheimer's disease.